Akira Miyazato

Akira Miyazato is the Site Head and Vice President of Clinical Development Japan at HUYA Bioscience International. Miyazato is also the CEO of EMHCS INC, with a background in Health Care, Medicine, Nursing Care, Pharmaceuticals, and ICT Innovation. Miyazato previously held positions at グラクソスミスクライン株式会社 as a Vice Center Manager and Department Manager in rare disease pharmaceutical development and antibody/oncology drug development respectively. Miyazato holds a Doctor of Medicine degree in molecular biology and bioinformatics from Jichi Medical University and a Bachelor of Medicine degree from the University of the Ryukyus.